A 2.6% Benzoyl Peroxide AV Cleanser Specifically Designed for Sensitive Skin Offers Good Efficacy and Tolerability

Study Highlights: 2.6% Benzoyl Peroxide AV Cleanser for Sensitive Skin

Effective and Well-Tolerated Treatment for Acne Vulgaris

A clinical study evaluated the efficacy and safety of a 2.6% Benzoyl Peroxide (BPO) cleanser designed for sensitive skin in treating mild-to-moderate acne vulgaris (AV). The results showed a significant reduction in AV lesions as early as one week of use, with a trend of continued improvement over four weeks. Additionally, the cleanser demonstrated a notable decrease in porphyrin counts, indicating its effectiveness in addressing AV.

Well-Tolerated and Liked by Patients

The study found that the 2.6% BPO cleanser was well tolerated by subjects with self-perceived sensitive skin, with no significant increase in tolerability ratings compared to baseline. Patients reported good satisfaction with the product, highlighting its potential for use in individuals with sensitive skin.

Practical Solutions for Clinics and Healthcare Providers

Streamlining Operations with AI-Driven Platforms

Utilizing AI-driven platforms such as DocSym can help clinicians consolidate clinical protocols and research, providing a comprehensive knowledge base aligned with ICD-11 standards. This streamlines operations and facilitates the integration of clinical research into everyday medical practice.

Enhancing Patient Care and Services Digitally

Mobile apps that support scheduling, treatment monitoring, and telemedicine offer practical solutions for managing patient care and expanding services digitally. These tools contribute to improved workflows, patient outcomes, and the reduction of paper-based routines in healthcare settings.